Semi-Annual Consolidated Statement Of Cash Flows

SAPPORO CLINICAL LABORATORY INC. - Filing #7300487

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
502,253,000 JPY
761,134,000 JPY
Interest and dividends received
2,834,000 JPY
2,858,000 JPY
Interest paid
-3,528,000 JPY
-3,624,000 JPY
Income taxes paid
-123,048,000 JPY
-89,046,000 JPY
Net cash provided by (used in) operating activities
406,832,000 JPY
809,541,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-591,795,000 JPY
-185,423,000 JPY
Proceeds from sale of property, plant and equipment
1,556,000 JPY
27,845,000 JPY
Purchase of investment securities
0 JPY
0 JPY
Other, net
21,242,000 JPY
24,383,000 JPY
Net cash provided by (used in) investing activities
-583,820,000 JPY
-170,535,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-68,521,000 JPY
-65,171,000 JPY
Purchase of treasury shares
-189,975,000 JPY
JPY
Dividends paid
-76,537,000 JPY
-76,513,000 JPY
Net cash provided by (used in) financing activities
-398,218,000 JPY
-237,969,000 JPY
Dividends paid to non-controlling interests
JPY
-32,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-575,206,000 JPY
401,036,000 JPY
Cash and cash equivalents
3,390,999,000 JPY
3,966,205,000 JPY
4,055,085,000 JPY
3,654,048,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.